Pfizer Inc. (PFE)

34.37
0.86 2.60
NYSE
Prev Close 33.51
Open 33.51
Day Low/High 33.44 / 34.45
52 Wk Low/High 27.88 / 43.08
Volume 45.84M
Exchange NYSE
Shares Outstanding 5577.63B
Market Cap 187.91B
P/E Ratio 23.58
Div & Yield N.A. (N.A)
Let's Take a Look at Pfizer Partner BioNTech's Charts

Let's Take a Look at Pfizer Partner BioNTech's Charts

Aggressive traders who have dug into the fundamentals of this German-based company could look to go long.

2 Energy Stocks With Promise: A Technical Look

2 Energy Stocks With Promise: A Technical Look

Let's head to the oil patch for a look at Chevron and Pioneer Natural Resources.

The Thunder in South Florida Yesterday Was Not the Bad Weather - It Was the Sound of the Market's Pivot From Growth to Value

* Yesterday may have represented a classic "sell on the good news" * While many were cheering about the vaccine news, I was waiting to sell, red tickets in hand * Some stocks and sectors had a great year yesterday * And some stocks and sectors got s...

Vaccine Rotation, What I Bought and Sold, Stocks on Thin Ice, Apple's Event

Vaccine Rotation, What I Bought and Sold, Stocks on Thin Ice, Apple's Event

What the Nasdaq experienced Monday is known not just as an 'Outside Day,' but an 'Outside Reversal,' and these can be dangerous.

Vaccine News Triggers Vicious Rotational Action

Vaccine News Triggers Vicious Rotational Action

The Russell 2000 outperformed the Nasdaq by 5.2 percentage points on Monday -- the largest outperformance ever recorded between the two indices.

Injection of Vaccine Hope Spurs a Messy Rally

Injection of Vaccine Hope Spurs a Messy Rally

The sloppy day wasn't nearly as positive as you'd think based on the action in the Dow and S&P 500, and the question now is what comes next?

Jim Cramer: Even With New Covid Weapon, the Fight Goes On

Jim Cramer: Even With New Covid Weapon, the Fight Goes On

We are going to win the war, but battles are still ahead. Here's how to invest in the meantime.

What Does a 3-Sigma Move Mean for Markets?

What Does a 3-Sigma Move Mean for Markets?

Ask yourself if anything has really changed.

A Dose of Good News Spurs a 'Buy Everything' Rally

A Dose of Good News Spurs a 'Buy Everything' Rally

Here's how to position yourself now that news of the Pfizer vaccine has landed, and what's happening with the 'haves,' 'have nots' and Treasuries.

Vaccine News Produces Overreactions in Both Directions

Vaccine News Produces Overreactions in Both Directions

This is a very extended market that is now even more extended.

What the Vaccine News Means for Stocks and the Market

What the Vaccine News Means for Stocks and the Market

When the dust settles midweek, I believe we'll have a great feel for the longer-term outlook associated with the Pfizer news.

Resistance Levels Likely No Match for Vaccine Rally

Resistance Levels Likely No Match for Vaccine Rally

Monday's vaccine news may well further improve the charts technically.

Pfizer's Ureka Moment and Why Winning Is Never Boring

Pfizer's Ureka Moment and Why Winning Is Never Boring

The leaders now are suddenly the reopening stocks, while the work remotely and stay at home stocks are being sold.

Pfizer Vaccine Causes a Frenzy of Buying

Pfizer Vaccine Causes a Frenzy of Buying

The vaccine news marks a major turning point and the issue now is to navigate this rotation.

Have the Charts of Pfizer Changed Monday Morning?

Have the Charts of Pfizer Changed Monday Morning?

Let's take a look amid the announcement that Pfizer's Covid-19 vaccine has progressed further.

My Election Day Wish, Tech Sector Performance, Trading Amazon and 6 Other Stocks

My Election Day Wish, Tech Sector Performance, Trading Amazon and 6 Other Stocks

Here's to the removal of uncertainty -- and thousands of campaign signs on thousands of lawns in my neighborhood.

I'm Long Moderna and Here's Why

I'm Long Moderna and Here's Why

The focus when it comes to MRNA is the timing of mRNA-1273, the firm's two dose hopeful protection against Covid.

Surviving in This Environment, Shaky Recovery, Lilly and Pfizer Setbacks

Surviving in This Environment, Shaky Recovery, Lilly and Pfizer Setbacks

The 'work from home' or 'economic lockdown' trade is close to being back on.

Red Monday, Virus Rattles Market, Political Picture, Aerospace & Defense Stocks

Red Monday, Virus Rattles Market, Political Picture, Aerospace & Defense Stocks

This is a major earnings week, electoral risk is real, the virus is already slowing velocity, and the cavalry (fiscal policy) is not coming. Sometimes, circling the wagons is not the worst idea.

Pfizer Is Trading a Lot on Hopes Ahead of Earnings

Pfizer Is Trading a Lot on Hopes Ahead of Earnings

Investors are not positioned for an upside move.

Politics and the Virus, Unpriced Risk, Monster Earnings

Politics and the Virus, Unpriced Risk, Monster Earnings

There is no stimulus deadline. There is no deal. There are only the games people play.

4 Straight Days, Troubling Trend?, Dollar Weakness, FDA Meets, Pfizer Vaccine

4 Straight Days, Troubling Trend?, Dollar Weakness, FDA Meets, Pfizer Vaccine

Several sessions over the past 10 days have seen increased trading volume at the NYSE, but not the Nasdaq, and for the S&P 500, but not the Nasdaq Composite. Is this professional risk reduction?

3 'Pick & Shovel' Stock Plays in Covid Vaccine Development

3 'Pick & Shovel' Stock Plays in Covid Vaccine Development

Investors are chasing every name that's developing a promising coronavirus vaccine. These stocks will be winners no matter which companies are successful.

Covid Drug Candidates, Buy Eli Lilly? Large Cap Stocks, Tesla Debt Upgrade

Covid Drug Candidates, Buy Eli Lilly? Large Cap Stocks, Tesla Debt Upgrade

Covid itself, and therapeutics or vaccines associated with taking on the SARS-CoV-2 coronavirus, is under a public microscope.

Pelosi's Hardball Gambit, Playing Small Ball, Promising Vaccine Outlook

Pelosi's Hardball Gambit, Playing Small Ball, Promising Vaccine Outlook

Plus, there's talk of a possible combination of Advanced Micro Devices and Xilinx.

Stimulus Repercussions, Is the Equities Rally Dead? Antitrust Action, Apple 5G

Stimulus Repercussions, Is the Equities Rally Dead? Antitrust Action, Apple 5G

One day after deciding that we still could not confirm the market's uptrend, we are forced to ask the opposite.

DC Do-Over, October Volatility, Positive Technicals, Datadog Breakout, Moderna

DC Do-Over, October Volatility, Positive Technicals, Datadog Breakout, Moderna

Suddenly, both sides realize that they have played politics and the people had noticed. Not those two from Tuesday night. Thankfully.

Jim Cramer: You Heard the Ugly of the Debate. Here's the Good.

Jim Cramer: You Heard the Ugly of the Debate. Here's the Good.

Neither candidate seems to be the enemy of the market -- at least not yet.

Pfizer Rated New Hold at Berenberg